Abstract
Both patient and provider should not underestimate the important role of the patient to exert agency or control over his or her own health. This chapter reviews the psychological construct of locus of control (LOC) as it applies to the treatment and management of CDH. Beginning with an overview of LOC and the related concept of self-efficacy, the chapter explores how these constructs have been measured and applied to understand the CDH population. In particular, research suggests that internal LOC and high self-efficacy are associated with favorable treatment outcomes for modifiable health behaviors of benefit to CDH patients. Two psychological treatments to enhance patient internal LOC and self-efficacy – cognitive-behavioral therapy (including biofeedback and use of relevant assessment tools) and motivational interviewing – are addressed. The chapter concludes with a discussion of suggestions for providers to increase their own LOC and self-efficacy in treating the CDH population, and concepts are illustrated with a case study.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rotter JB. Social learning and clinical psychology. New York (NY): Prentice-Hall; 1954.
Rotter JB. Generalized expectancies for internal versus external control of reinforcement. Psychol Monogr. 1966;80(1):1–28.
Wallston KA, Wallston BS. Who is responsible for your health? The construct of health locus of control. In: Sanders GS, Suls JM, editors. Social psychology of health and illness. Hillsdale (NJ): Lawrence Erlbaum; 1982. p. 65–95.
Wallston BS, Wallston KA, Kaplan GD, Maides SA. Development and validation of the health locus of control (HLC) scale. J Consult Clin Psychol. 1976;44(4):580–5.
Wallston KA, Wallston BS, DeVellis R. Development of the multidimensional health locus of control (MHLC) scales. Health Educ Monogr. 1978;6(1):160–70.
Berglund E, Lytsy P, Westerling R. The influence of locus of control on self-rated health in context of chronic disease: a structural equation modeling approach in a cross sectional study. BMC Public Health. 2014;14(1):492–500.
Grotz M, Hapke U, Lampert T, Baumeister H. Health locus of control and health behaviour: results from a nationally representative survey. Psychol Health Med. 2011;16(2):129–40.
O’Hea EL, Grothe KB, Bodenlos JS, Boudreaux ED, White MA, Brantley PJ. Predicting medical regimen adherence: the interactions of health locus of control beliefs. J Health Psychol. 2005;10(5):705–17.
Milte CM, Luszcz MA, Ratcliffe J, Masters S, Crotty M. Influence of health locus of control on recovery of function in recently hospitalized frail older adults. Geriatr Gerontol Int. 2015;15(3):341–9.
Cassidy T, Hilton S. Family health culture, health locus of control and health behaviours in older children. J Pediatric Med Care. 2017;1(1):4–9.
Bergvik S, Sørlie T, Wynn R. Coronary patients who returned to work had stronger internal locus of control beliefs than those who did not return to work. Br J Health Psychol. 2012;17(3):596–608.
Keedy NH, Keffala VJ, Altmaier EM, Chen JJ. Health locus of control and self-efficacy predict back pain rehabilitation outcomes. Iowa Orthop J. 2014;34:158–65.
Aarts JW, Deckx L, Abbema DL, Tjan-Heijnen VC, Akker M, Buntinx F. The relation between depression, coping and health locus of control: differences between older and younger patients, with and without cancer. Psychooncology. 2015;24(8):950–7.
Ahmedani BK, Peterson EL, Wells KE, Rand CS, Williams LK. Asthma medication adherence: the role of god and other health locus of control factors. Ann Allergy Asthma Immunol. 2013;110(2):75–9.
Martin NJ, Holroyd KA, Penzien DB. The headache-specific locus of control scale: adaptation to recurrent headaches. Headache. 1990;30(11):729–34.
VandeCreek L, O’Donnell F. Psychometric characteristics of the headache-specific locus of control scale. Headache. 1992;32(5):239–41.
Grinberg AS, Seng EK. Headache-specific locus of control and migraine-related quality of life: understanding the role of anxiety. Int J Behav Med. 2017;24(1):136–43.
French DJ, Holroyd KA, Pinell C, Malinoski PT, O'donnell F, Hill KR. Perceived self-efficacy and headache-related disability. Headache. 2000;40(8):647–56.
Seng EK, Holroyd KA. Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine. Ann Behav Med. 2010;40(3):235–47.
Seng EK, Buse DC, Klepper JE, J Mayson S, Grinberg AS, Grosberg BM, et al. Psychological factors associated with chronic migraine and severe migraine-related disability: an observational study in a tertiary headache center. Headache. 2017;57(4):593–604.
Nash JM, Williams DM, Nicholson R, Trask PC. The contribution of pain-related anxiety to disability from headache. J Behav Med. 2006;29(1):61–7.
Scharff L, Turk DC, Marcus DA. The relationship of locus of control and psychosocial-behavioral response in chronic headache. Headache. 1995;35(9):527–33.
Heath RL, Saliba M, Mahmassani O, Major SC, Khoury BA. Locus of control moderates the relationship between headache pain and depression. J Headache Pain. 2008;9(5):301–8.
Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):191–215.
Judge TA, Erez A, Bono JE, Thoresen CJ. Are measures of self-esteem, neuroticism, locus of control, and generalized self-efficacy indicators of a common core construct? J Pers Soc Psychol. 2002;83(3):693–710.
Luszczynska A, Schwarzer R. Multidimensional health locus of control: comments on the construct and its measurement. J Health Psychol. 2005;10(5):633–42.
O'Leary A. Self-efficacy and health: behavioral and stress-physiological mediation. Cognit Ther Res. 1992;16(2):229–45.
Lefebvre JC, Keefe FJ, Affleck G, Raezer LB, Starr K, Caldwell K, et al. The relationship of arthritis self-efficacy to daily pain, daily mood, and daily pain coping in rheumatoid arthritis patients. Pain. 1999;80:425–35.
Buckelew SP, Parker JC, Keefe FJ, Deuser WE, Crews TM, Conway R, et al. Self-efficacy and pain behavior among subjects with fibromyalgia. Pain. 1994;59(3):377–84.
Litt MD. Self-efficacy and perceived control: cognitive mediators of pain tolerance. J Pers Soc Psychol. 1988;54(1):149–60.
Wilcox S, Schoffman DE, Dowda M, Sharpe PA. Psychometric properties of the 8-item english arthritis self-efficacy scale in a diverse sample. Arthritis. 2014;2014:1–8.
Martin NJ, Holroyd KA, Rokicki LA. The headache self-efficacy scale: adaptation to recurrent headaches. Headache. 1993;33(5):244–8.
Seng EK, Nicholson RA, Holroyd KA. Development of a measure of self-efficacy for acute headache medication adherence. J Behav Med. 2016;39(6):1033–42.
Peck KR, Smitherman TA. Mediator variables in headache research: methodological critique and exemplar using self-efficacy as a mediator of the relationship between headache severity and disability. Headache. 2015;55(8):1102–11.
Nicholson RA, Smith TR. Predicting self-efficacy, satisfaction with care, and headache impact among migraine sufferers in a primary care setting. Headache. 2006;46(5):874.
Nicholson RA, Houle TT, Rhudy JL, Norton PJ. Psychological risk factors in headache. Headache. 2007;47(3):413–26.
Parsons T. The sick role and the role of the physician reconsidered. Milbank Mem Fund Q Health Soc. 1975;53(3):257–78.
Heidarnia MA, Heidarnia A. Sick role and a critical evaluation of its application to our understanding of the relationship between physicians and patients. Novel Biomed. 2016;4(3):126–34.
Ehde DM, Dillworth TM, Turner JA. Cognitive-behavioral therapy for individuals with chronic pain: efficacy, innovations, and directions for research. Am Psychol. 2014;69(2):153–66.
Turner JA, Romano JM. Cognitive-behavioral therapy for chronic pain. In: Loeser JD, Bonica JJ, editors. Bonica’s management of pain. 3rd ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2001. p. 1751–8.
Penzien DB, Andrasik F, Freidenberg BM, Houle TT, Lake AE, Lipchik GL, et al. Guidelines for trials of behavioral treatments for recurrent headache, first edition, American headache society behavioral clinical trials workgroup. Headache. 2005;45(S2):S110–32.
Jacobson E. Progressive relaxation: a physiological and clinical investigation of muscular state and their significance. Chicago (IL): University of Chicago Press; 1938.
Blanchard EB, Andrasik F. Biofeedback treatment of vascular headache. In: Hatch JP, Fisher JG, Rugh J, editors. Biofeedback studies in clinical efficacy. New York (NY): Plenum Press; 1987. p. 1–79.
Blanchard EB, Andrasik F, Ahles TA, Teders SJ, O’Keefe D. Migraine and tension headache: a meta-analytic review. Behav Ther. 1980;11(5):613–31.
Nestoriuc Y, Martin A, Rief W, Andrasik F. Biofeedback treatment for headache disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2008;33(3):125–40.
Nestoriuc Y, Reif W, Martin A. Meta-analysis of biofeedback for tension-type headache: efficacy, specificity, and treatment moderators. J Consult Clin Psychol. 2008;76(3):379–96.
Grazzi L, Andrasik F, D’Amico D, Leone M, Usai S, Kass SJ, et al. Behavioral and pharmacologic treatment of transformed migraine with analgesic overuse: outcome at 3 years. Headache. 2002;42(6):483–90.
Andrasik F. Behavioral treatment of migraine: current status and future directions. Expert Rev Neurother. 2004;4(3):403–13.
Holroyd KA, France JL, Cordingley GE, Rokicki LA, Kvaal SA, Lipchik GL, et al. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol. 1995;63(2):327–30.
Wilson AM. Heart rate variability biofeedback training as an intervention for chronic pain. PhD [dissertation]. Milwaukee (WI): Marquette University; 2017.
Nicholson R, Nash J, Andrasik F. A self-administered behavioral intervention using tailored messages for migraine. Headache. 2005;45(9):1124–39.
Cano-Garcia FJ, Rodriguez-Franco L, Lopez-Jimenez AM. A shortened version of the headache-specific locus of control scale in Spanish population. Headache. 2010;50(8):1335–45.
Sullivan M, Bishop SR, Pivik J. The pain catastrophizing scale: development and validation. Psychol Assess. 1995;7(4):524–32.
Terkawi AS, Sullivan M, Abolkhair A, Al-Zhahrani T, Terkawi RS, Alasfar EM, et al. Development and validation of Arabic version of the pain catastrophizing scale. Saudi J Anaesth. 2017;11(S1):S63–70.
Cho S, Kim HY, Lee JH. Validation of the Korean version of the pain catastrophizing scale in patients with chronic non-cancer pain. Qual Life Res. 2013;22(7):1767–72.
Bansal D, Gudala K, Lavudiya S, Ghai B, Arora P. Translation, adaptation, and validation of Hindi version of the pain catastrophizing scale in patients with chronic low back pain for use in India. Pain Med. 2016;17(10):1848–58.
Suren M, Okan I, Gokbakan AM, Kaya Z, Erkorkmaz U, Arici S, et al. Factors associated with the pain catastrophizing scale and validation in a sample of the Turkish population. Turk J Med Sci. 2014;44(1):104–8.
Lopes RA, Dias RC, Queiroz BZ, Rosa NM, Pereira Lde S, Dias JM, et al. Psychometric properties of the Brazilian version of the pain catastrophizing scale for acute low back pain. Arq Neuropsiquiatr. 2015;73(5):436–44.
Pallegama RW, Ariyawardana A, Ranasinghe AW, Sitheeque M, Glaros AG, Dissanayake WP, et al. The Sinhala version of the pain catastrophizing scale: validation and establishment of the factor structure in pain patients and healthy adults. Pain Med. 2014;15(10):1734–42.
Meroni R, Piscitelli D, Bonetti F, Zambaldi M, Cerri CG, Guccione AA, et al. Rasch analysis of the Italian version of pain catastrophizing scale (PCS-I). J Back Musculoskelet Rehabil. 2015;28(4):661–73.
Kroner-Herwig B, Maas J. The German pain catastrophizing scale for children (PCS-C) - psychometric analysis and evaluation of the construct. Psychosoc Med. 2013;10:Doc07.
Sole E, Castarlenas E, Miro J. A Catalan adaptation and validation of the pain catastrophizing scale for children. Psychol Assess. 2016;28(6):e119–26.
McWilliams LA, Kowal J, Wilson KG. Development and evaluation of short forms of the pain catastrophizing scale and the pain self-efficacy questionnaire. Eur J Pain. 2015;19(9):1342–9.
Nishigami T, Mibu A, Tanaka K, Yamashita Y, Watanabe A, Tanabe A. Psychometric properties of the Japanese version of short forms of the pain catastrophizing scale in participants with musculoskeletal pain: a cross-sectional study. J Orthop Sci. 2017;22(2):351–6.
Lundahl B, Moleni T, Burke BL, Butters R, Tollefson D, Butler C, et al. Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials. Patient Edu Couns. 2013;93(2):157–68.
Stevens J, Hayes J, Pakalnis A. A randomized trial of telephone-based motivational interviewing for adolescent chronic headache with medication overuse. Cephalalgia. 2014;34(6):446–54.
Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care: helping patients change behavior. New York (NY): Guilford Press; 2008.
Miller W, Rollnick S. Motivational interviewing: preparing people for change. New York (NY): Guilford Press; 2002.
Prochaska JO, DiClemente CC. Transtheoretical therapy: toward a more integrative model of change. Psychother Theor Res Pract. 1982;19(3):276–88.
Miller W, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. New York (NY): Guilford Press; 1991.
Haas LJ, Leiser JP, Magill MK, Sanyer ON. Management of the difficult patient. Am Fam Physician. 2005;72(10):2063–8.
Cottrell CK, Drew JB, Waller SE, Holroyd KA, Brose JA, O’Donnell FJ. Perceptions and needs of patients with migraine: a focus group study. J Fam Pract. 2002;51(2):142–7.
Loder E. The approach to the difficult patient. Handb Clin Neurol. 2010;97:233–8.
Cho SJ, Chu MK. Risk factors of chronic daily headache or chronic migraine. Curr Pain Headache Rep. 2015;19(1):465.
Grazzi L. Behavioural approach to the “difficult” patient. Neurol Sci. 2008;29(S1):S96–8.
Rains JC, Lipchik GL, Penzien DB. Behavioral facilitation of medical treatment for headache–part 1: review of headache treatment compliance. Headache. 2006;46(9):1387–94.
Wilson AM, Melchert T, Anderson RC. Biofeedback facilitates greater pain control in a diverse sample of patients with chronic pain. Unpublished manuscript. 2018.
Acknowledgments
The authors wish to thank Annette Wilson, Ph.D., for her contributions to the chapter, in particular the results of her biofeedback study.
Correspondence regarding this chapter should be addressed to Sarah E. Trost, Pain Management Center, Department of Anesthesiology, Medical College of Wisconsin, 959 N. Mayfair Rd., Wauwatosa, WI 53226.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Trost, S.E., Seipel, M.T., Kalscheur, E.J., Anderson, R.C. (2019). Refractory Headache or Refractory Patient? Issues of Locus of Control in Chronic Daily Headache (CDH). In: Green, M., Cowan, R., Freitag, F. (eds) Chronic Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-91491-6_2
Download citation
DOI: https://doi.org/10.1007/978-3-319-91491-6_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-91490-9
Online ISBN: 978-3-319-91491-6
eBook Packages: MedicineMedicine (R0)